SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

SAN

77.51

+0.81%↑

ARGX

704.2

+0.46%↑

SHL.DE

35.06

+1.39%↑

FRE

38.4

-1.13%↓

PHIA

23.76

+1.45%↑

Home・Listă Acțiuni・Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi SA

Închisă

SectorSănătate

60.2 2.03

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

60.3

Indicatori cheie
By Trading Economics
Venit	-33M 9.5M
Vânzări	-66M 152M
P/E Medie Sector	24.576 49.701
EPS	0.185
Marjă de profit	6.216
Angajați	1,950
EBITDA	-45M 18M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+24.64% upside

Dividende
By Dow Jones
Următoarele câștiguri	23 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-1.1B 3B
Deschiderea anterioară	58.17
Închiderea anterioară	60.2

Sentimentul știrilor

By Acuity

50%

151 / 345 Clasament în Healthcare

Laboratorios Farmaceuticos Rovi SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 mai 2026, 23:46 UTC

Market Talk

Pullback in Oil Prices Could Temper Inflation Expectations -- Market Talk

24 mai 2026, 23:45 UTC

Market Talk

Gold, Silver Rise on Hopes for U.S.-Iran Deal -- Market Talk

24 mai 2026, 23:42 UTC

Market Talk

Mineral Resources Bull More Positive Post Site Visit -- Market Talk

24 mai 2026, 23:34 UTC

Market Talk

Oil Falls Amid Prospects for Reopening of Strait of Hormuz -- Market Talk

24 mai 2026, 23:11 UTC

Market Talk

RBNZ Likely to Stand Pat But Watch for Dissent -- Market Talk

24 mai 2026, 22:26 UTC

Achiziții, Fuziuni, Preluări

Beach Energy: La Bella 2 Will No Longer Be Drilled as Part of Equinox Campaign

24 mai 2026, 22:25 UTC

Achiziții, Fuziuni, Preluări

Beach Energy: Implied Transaction Value of Around A$130 Million After Tax

24 mai 2026, 22:25 UTC

Achiziții, Fuziuni, Preluări

Beach Energy: Royalty Payments Likely to Total Around A$140 Million Based on Resource Booking

24 mai 2026, 22:24 UTC

Achiziții, Fuziuni, Preluări

Beach Energy to Get Production Royalty of A$3.75/GJ in Deal

24 mai 2026, 22:24 UTC

Achiziții, Fuziuni, Preluări

Beach Energy to Get A$70 Million Cash Proceeds When Deal Completes

24 mai 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Beach Energy Says Deal Includes Artisan Natural-Gas Discovery

24 mai 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Beach Energy Sells 60% Operated Interest in VIC/L35 Block in Otway Basin

24 mai 2026, 22:11 UTC

Market Talk

Oil Price Unlikely to Return to Pre-Conflict Levels This Year -- Market Talk

24 mai 2026, 22:04 UTC

Market Talk

Oil Price Likely Lower, Equities Higher on Iran Deal Talks Progress -- Market Talk

23 mai 2026, 08:20 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

23 mai 2026, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

22 mai 2026, 21:10 UTC

Câștiguri

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

22 mai 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

22 mai 2026, 20:50 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Financial Services Roundup: Market Talk

22 mai 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

22 mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22 mai 2026, 19:47 UTC

Câștiguri

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

22 mai 2026, 19:17 UTC

Market Talk

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

22 mai 2026, 19:10 UTC

Market Talk

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

22 mai 2026, 18:54 UTC

Market Talk

Global Equities Roundup: Market Talk

22 mai 2026, 18:54 UTC

Market Talk

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

22 mai 2026, 18:38 UTC

Market Talk

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

22 mai 2026, 18:35 UTC

Achiziții, Fuziuni, Preluări

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

22 mai 2026, 18:09 UTC

Market Talk

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 mai 2026, 17:58 UTC

Market Talk

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

Comparație

Modificare preț

Laboratorios Farmaceuticos Rovi SA Așteptări

Obiectiv de preț

By TipRanks

24.64% sus

Prognoză pe 12 luni

Medie 73.6 EUR 24.64%

Maxim 83 EUR

Minim 64.2 EUR

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruLaboratorios Farmaceuticos Rovi SA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 2 analiști care au acordat evaluări ale acțiunilor Laboratorios Farmaceuticos Rovi SA - Dist în ultimele 3 luni.

Sentiment

By Acuity

151 / 345 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.